Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 136

    1.

    Analysis of hepatitis C virus intrahost diversity across the coding region by ultradeep pyrosequencing.

    Lauck M, Alvarado-Mora MV, Becker EA, Bhattacharya D, Striker R, Hughes AL, Carrilho FJ, O'Connor DH, Pinho JR.

    J Virol. 2012 Apr;86(7):3952-60. Epub 2012 Jan 25.

    PMID:
    22278255
    [PubMed - in process]
    2.

    Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function.

    McCaffrey K, Boo I, Tewierek K, Edmunds ML, Poumbourios P, Drummer HE.

    J Virol. 2012 Apr;86(7):3961-74. Epub 2012 Jan 25.

    PMID:
    22278231
    [PubMed - in process]
    3.

    Hepatitis C virus infection of human T lymphocytes is mediated by CD5.

    Sarhan MA, Pham TN, Chen AY, Michalak TI.

    J Virol. 2012 Apr;86(7):3723-35. Epub 2012 Jan 25.

    PMID:
    22278227
    [PubMed - in process]
    4.

    Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.

    Horner SM, Park HS, Gale M Jr.

    J Virol. 2012 Mar;86(6):3112-20. Epub 2012 Jan 11.

    PMID:
    22238314
    [PubMed - indexed for MEDLINE]
    5.

    Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization.

    Tarr AW, Urbanowicz RA, Jayaraj D, Brown RJ, McKeating JA, Irving WL, Ball JK.

    J Virol. 2012 Mar;86(5):2739-49. Epub 2011 Dec 14.

    PMID:
    22171278
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Limited effects of bile acids and small heterodimer partner on hepatitis B virus biosynthesis in vivo.

    Reese VC, Moore DD, McLachlan A.

    J Virol. 2012 Mar;86(5):2760-8. Epub 2011 Dec 14.

    PMID:
    22171277
    [PubMed - indexed for MEDLINE]
    7.

    Hepatitis C virus proteins inhibit C3 complement production.

    Mazumdar B, Kim H, Meyer K, Bose SK, Di Bisceglie AM, Ray RB, Ray R.

    J Virol. 2012 Feb;86(4):2221-8. Epub 2011 Dec 14.

    PMID:
    22171262
    [PubMed - indexed for MEDLINE]
    8.

    Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1.

    Murayama A, Kato T, Akazawa D, Sugiyama N, Date T, Masaki T, Nakamoto S, Tanaka Y, Mizokami M, Yokosuka O, Nomoto A, Wakita T.

    J Virol. 2012 Feb;86(4):2143-52. Epub 2011 Dec 7.

    PMID:
    22156532
    [PubMed - indexed for MEDLINE]
    9.

    Creation of a nonspreading Rift Valley fever virus.

    Kortekaas J, Oreshkova N, Cobos-Jiménez V, Vloet RP, Potgieter CA, Moormann RJ.

    J Virol. 2011 Dec;85(23):12622-30. Epub 2011 Sep 28.

    PMID:
    21957302
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Characterization of wild-type and alternate transcription termination signals in the Rift Valley fever virus genome.

    Lara E, Billecocq A, Leger P, Bouloy M.

    J Virol. 2011 Dec;85(23):12134-45. Epub 2011 Sep 14.

    PMID:
    21917943
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    Autophagy required for hepatitis B virus replication in transgenic mice.

    Tian Y, Sir D, Kuo CF, Ann DK, Ou JH.

    J Virol. 2011 Dec;85(24):13453-6. Epub 2011 Sep 28.

    PMID:
    21957292
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Proline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2), a host membrane-deforming protein, is critical for membranous web formation in hepatitis C virus replication.

    Chao TC, Su WC, Huang JY, Chen YC, Jeng KS, Wang HD, Lai MM.

    J Virol. 2012 Feb;86(3):1739-49. Epub 2011 Nov 30.

    PMID:
    22130530
    [PubMed - indexed for MEDLINE]
    13.

    Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b.

    Raghwani J, Thomas XV, Koekkoek SM, Schinkel J, Molenkamp R, van de Laar TJ, Takebe Y, Tanaka Y, Mizokami M, Rambaut A, Pybus OG.

    J Virol. 2012 Feb;86(4):2212-20. Epub 2011 Nov 23.

    PMID:
    22114341
    [PubMed - indexed for MEDLINE]
    14.

    Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122.

    Kambara H, Fukuhara T, Shiokawa M, Ono C, Ohara Y, Kamitani W, Matsuura Y.

    J Virol. 2012 Feb;86(3):1382-93. Epub 2011 Nov 23.

    PMID:
    22114337
    [PubMed - indexed for MEDLINE]
    15.

    Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway.

    Zhang Q, Gong R, Qu J, Zhou Y, Liu W, Chen M, Liu Y, Zhu Y, Wu J.

    J Virol. 2012 Feb;86(3):1544-54. Epub 2011 Nov 23.

    PMID:
    22114332
    [PubMed - indexed for MEDLINE]
    16.

    Duck Hepatitis A virus possesses a distinct type IV internal ribosome entry site element of picornavirus.

    Pan M, Yang X, Zhou L, Ge X, Guo X, Liu J, Zhang D, Yang H.

    J Virol. 2012 Jan;86(2):1129-44. Epub 2011 Nov 16.

    PMID:
    22090106
    [PubMed - indexed for MEDLINE]
    17.

    Hepatitis C virus fails to activate NF-κB signaling in plasmacytoid dendritic cells.

    Dental C, Florentin J, Aouar B, Gondois-Rey F, Durantel D, Baumert TF, Nunes JA, Olive D, Hirsch I, Stranska R.

    J Virol. 2012 Jan;86(2):1090-6. Epub 2011 Nov 16.

    PMID:
    22090103
    [PubMed - indexed for MEDLINE]
    18.

    Conserved glycine 33 residue in flexible domain I of hepatitis C virus core protein is critical for virus infectivity.

    Angus AG, Loquet A, Stack SJ, Dalrymple D, Gatherer D, Penin F, Patel AH.

    J Virol. 2012 Jan;86(2):679-90. Epub 2011 Nov 9.

    PMID:
    22072760
    [PubMed - indexed for MEDLINE]
    19.

    Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.

    Ruhl M, Chhatwal P, Strathmann H, Kuntzen T, Bankwitz D, Skibbe K, Walker A, Heinemann FM, Horn PA, Allen TM, Hoffmann D, Pietschmann T, Timm J.

    J Virol. 2012 Jan;86(2):991-1000. Epub 2011 Nov 9.

    PMID:
    22072759
    [PubMed - indexed for MEDLINE]
    20.

    Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.

    Desmond CP, Gaudieri S, James IR, Pfafferott K, Chopra A, Lau GK, Audsley J, Day C, Chivers S, Gordon A, Revill PA, Bowden S, Ayres A, Desmond PV, Thompson AJ, Roberts SK, Locarnini SA, Mallal SA, Lewin SR.

    J Virol. 2012 Jan;86(2):1181-92. Epub 2011 Nov 9.

    PMID:
    22072755
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk